UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 245

Sortiert nach

Identification of a potent benzoxaborole drug candidate for treating cryptosporidiosis

Nature communications, 2019-06, Vol.10 (1), p.2816-11, Article 2816

2019

Link zum Volltext

Verfügbarkeit prüfen

Benzoxaborole Antimalarial Agents. Part 5. Lead Optimization of Novel Amide Pyrazinyloxy Benzoxaboroles and Identification of a Preclinical Candidate

Journal of medicinal chemistry, 2017-07, Vol.60 (13), p.5889-5908

2017

Link zum Volltext

Verfügbarkeit prüfen

Antifungal Agent Inhibits an Aminoacyl-tRNA Synthetase by Trapping tRNA in the Editing Site

Science (American Association for the Advancement of Science), 2007-06, Vol.316 (5832), p.1759-1761

2007

Link zum Volltext

Verfügbarkeit prüfen

Discovery and structure–activity study of a novel benzoxaborole anti-inflammatory agent (AN2728) for the potential topical treatment of psoriasis and atopic dermatitis

Bioorganic & medicinal chemistry letters, 2009-04, Vol.19 (8), p.2129-2132

2009

Link zum Volltext

Verfügbarkeit prüfen

Discovery of a New Boron-Containing Antifungal Agent, 5-Fluoro-1,3-dihydro-1-hydroxy-2,1- benzoxaborole (AN2690), for the Potential Treatment of Onychomycosis

Journal of medicinal chemistry, 2006-07, Vol.49 (15), p.4447-4450

2006

Link zum Volltext

Verfügbarkeit prüfen

Crystal Structures of the Human and Fungal Cytosolic Leucyl-tRNA Synthetase Editing Domains: A Structural Basis for the Rational Design of Antifungal Benzoxaboroles

Journal of molecular biology, 2009-07, Vol.390 (2), p.196-207

2009

Link zum Volltext

Verfügbarkeit prüfen

Plasmodium falciparum Resistance to a Lead Benzoxaborole Due to Blocked Compound Activation and Altered Ubiquitination or Sumoylation

mBio, 2020-01, Vol.11 (1)

2020

Link zum Volltext

Verfügbarkeit prüfen

In vivo efficacy of the boron-pleuromutilin AN11251 against Wolbachia of the rodent filarial nematode Litomosoides sigmodontis

PLoS neglected tropical diseases, 2020-01, Vol.14 (1), p.e0007957-e0007957

2020

Link zum Volltext

Verfügbarkeit prüfen

Discovery of an orally bioavailable isoxazoline benzoxaborole (AN8030) as a long acting animal ectoparasiticide

Bioorganic & medicinal chemistry letters, 2015-12, Vol.25 (23), p.5589-5593

2015

Link zum Volltext

Verfügbarkeit prüfen

Discovery and structure–activity relationships of 6-(benzoylamino)benzoxaboroles as orally active anti-inflammatory agents

Bioorganic & medicinal chemistry letters, 2013-11, Vol.23 (21), p.5870-5873

2013

Link zum Volltext

Verfügbarkeit prüfen

Discovery of a Potent and Specific M. tuberculosis Leucyl-tRNA Synthetase Inhibitor: (S)‑3-(Aminomethyl)-4-chloro-7-(2-hydroxyethoxy)benzo[c][1,2]oxaborol-1(3H)‑ol (GSK656)

Journal of medicinal chemistry, 2017-10, Vol.60 (19), p.8011-8026

2017

Link zum Volltext

Verfügbarkeit prüfen

Topical Treatment for Cutaneous Leishmaniasis: Dermato-Pharmacokinetic Lead Optimization of Benzoxaboroles

Antimicrobial agents and chemotherapy, 2018-05, Vol.62 (5)

2018

Link zum Volltext

Verfügbarkeit prüfen

SCYX-7158, an orally-active benzoxaborole for the treatment of stage 2 human African trypanosomiasis

PLoS neglected tropical diseases, 2011-06, Vol.5 (6), p.e1151

2011

Link zum Volltext

Verfügbarkeit prüfen

Identification of a 4-fluorobenzyl l-valinate amide benzoxaborole (AN11736) as a potential development candidate for the treatment of Animal African Trypanosomiasis (AAT)

Bioorganic & medicinal chemistry letters, 2018-01, Vol.28 (1), p.6-10

2018

Link zum Volltext

Verfügbarkeit prüfen

Boron-based drugs as antiprotozoals

Current opinion in infectious diseases, 2011-12, Vol.24 (6), p.586-592

2011

Link zum Volltext

Verfügbarkeit prüfen

Boron-based phosphodiesterase inhibitors show novel binding of boron to PDE4 bimetal center

FEBS letters, 2012-09, Vol.586 (19), p.3410-3414

2012

Link zum Volltext

Verfügbarkeit prüfen

Discovery of a Novel Class of Boron-Based Antibacterials with Activity against Gram-Negative Bacteria

Antimicrobial Agents and Chemotherapy, 2013-03, Vol.57 (3), p.1394-1403

2013

Link zum Volltext

Verfügbarkeit prüfen

Benzoxaborole Antimalarial Agents. Part 4. Discovery of Potent 6‑(2-(Alkoxycarbonyl)pyrazinyl-5-oxy)-1,3-dihydro-1-hydroxy-2,1-benzoxaboroles

Journal of medicinal chemistry, 2015-07, Vol.58 (13), p.5344-5354

2015

Link zum Volltext

Verfügbarkeit prüfen

Design, Synthesis, and Structure−Activity Relationship of Trypanosoma brucei Leucyl-tRNA Synthetase Inhibitors as Antitrypanosomal Agents

Journal of medicinal chemistry, 2011-03, Vol.54 (5), p.1276-1287

2011

Link zum Volltext

Verfügbarkeit prüfen

From the Test Tube to the Treatment Room: Fundamentals of Boron-containing Compounds and their Relevance to Dermatology

The Journal of clinical and aesthetic dermatology, 2014-02, Vol.7 (2), p.13-21

2014

Link zum Volltext

Verfügbarkeit prüfen

Synthesis and SAR of novel benzoxaboroles as a new class of β-lactamase inhibitors

Bioorganic & medicinal chemistry letters, 2011-04, Vol.21 (8), p.2533-2536

2011

Link zum Volltext

Verfügbarkeit prüfen

Optimization of isoxazoline amide benzoxaboroles for identification of a development candidate as an oral long acting animal ectoparasiticide

Bioorganic & medicinal chemistry letters, 2016-07, Vol.26 (13), p.3182-3186

2016

Link zum Volltext

Verfügbarkeit prüfen

Novel synthesis of isoxazoline indolizine amides for potential application to tropical diseases

Tetrahedron letters, 2014-03, Vol.55 (11), p.1936-1938

2014

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 245

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(156)
Mit Volltextzugriff
(171)

Publikationsform

Sprache

Englisch
(245)
Japanisch
(29)
Russisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(130)
Life Sciences & Biomedicine
(108)
Organic Chemistry
(103)
Pharmacology & Pharmacy
(91)
Chemistry, Medicinal
(81)
Chemistry
(79)
Structure-Activity Relationship
(79)
Animals
(74)
Physical Sciences
(55)
Biological And Medical Sciences
(53)
Medical Sciences
(51)
Pharmacology. Drug Treatments
(50)
Humans
(48)
Chemistry, Organic
(45)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(40)
Rats
(32)
Exact Sciences And Technology
(31)
Mice
(29)
Pharmacology
(29)
Preparations And Properties
(29)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Identification of a potent benzoxaborole drug candidate for treating cryptosporidiosis

Benzoxaborole Antimalarial Agents. Part 5. Lead Optimization of Novel Amide Pyrazinyloxy Benzoxaboroles and Identification of a Preclinical Candidate

Antifungal Agent Inhibits an Aminoacyl-tRNA Synthetase by Trapping tRNA in the Editing Site

Discovery and structure–activity study of a novel benzoxaborole anti-inflammatory agent (AN2728) for the potential topical treatment of psoriasis and atopic dermatitis

Discovery of a New Boron-Containing Antifungal Agent, 5-Fluoro-1,3-dihydro-1-hydroxy-2,1- benzoxaborole (AN2690), for the Potential Treatment of Onychomycosis

Crystal Structures of the Human and Fungal Cytosolic Leucyl-tRNA Synthetase Editing Domains: A Structural Basis for the Rational Design of Antifungal Benzoxaboroles

Plasmodium falciparum Resistance to a Lead Benzoxaborole Due to Blocked Compound Activation and Altered Ubiquitination or Sumoylation

In vivo efficacy of the boron-pleuromutilin AN11251 against Wolbachia of the rodent filarial nematode Litomosoides sigmodontis

Discovery of an orally bioavailable isoxazoline benzoxaborole (AN8030) as a long acting animal ectoparasiticide

Discovery and structure–activity relationships of 6-(benzoylamino)benzoxaboroles as orally active anti-inflammatory agents

Discovery of a Potent and Specific M. tuberculosis Leucyl-tRNA Synthetase Inhibitor: (S)‑3-(Aminomethyl)-4-chloro-7-(2-hydroxyethoxy)benzo[c][1,2]oxaborol-1(3H)‑ol (GSK656)

Discovery of Novel Oral Protein Synthesis Inhibitors of Mycobacterium tuberculosis That Target Leucyl-tRNA Synthetase

Topical Treatment for Cutaneous Leishmaniasis: Dermato-Pharmacokinetic Lead Optimization of Benzoxaboroles

SCYX-7158, an orally-active benzoxaborole for the treatment of stage 2 human African trypanosomiasis

Identification of a 4-fluorobenzyl l-valinate amide benzoxaborole (AN11736) as a potential development candidate for the treatment of Animal African Trypanosomiasis (AAT)

Boron-based drugs as antiprotozoals

Boron-based phosphodiesterase inhibitors show novel binding of boron to PDE4 bimetal center

Discovery of a Novel Class of Boron-Based Antibacterials with Activity against Gram-Negative Bacteria

Boron-Pleuromutilins as Anti-Wolbachia Agents with Potential for Treatment of Onchocerciasis and Lymphatic Filariasis

Benzoxaborole Antimalarial Agents. Part 4. Discovery of Potent 6‑(2-(Alkoxycarbonyl)pyrazinyl-5-oxy)-1,3-dihydro-1-hydroxy-2,1-benzoxaboroles

Design, Synthesis, and Structure−Activity Relationship of Trypanosoma brucei Leucyl-tRNA Synthetase Inhibitors as Antitrypanosomal Agents

From the Test Tube to the Treatment Room: Fundamentals of Boron-containing Compounds and their Relevance to Dermatology

Synthesis and SAR of novel benzoxaboroles as a new class of β-lactamase inhibitors

Optimization of isoxazoline amide benzoxaboroles for identification of a development candidate as an oral long acting animal ectoparasiticide

Novel synthesis of isoxazoline indolizine amides for potential application to tropical diseases

Suchergebnisse filtern